FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: Incidence and etiological considerations

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Modern Pathology (Impact Factor: 6.36). 03/2009; 22(5):627-632. DOI: 10.1038/modpathol.2009.28

ABSTRACT Urothelial papillomas and low-grade urothelial carcinomas have shown a high incidence of fibroblast growth factor receptor 3 (FGFR3) mutations and are associated with a favorable prognosis. The association of FGFR3 mutations with inverted papillomas is less known. We analyzed 20 cases of inverted papilloma in the urinary tract. Mutations of FGFR3 (exons 7, 10, and 15) and TP53 genes were evaluated by DNA sequencing in these cases. Point mutations of the FGFR3 gene were identified in 45% (9 of 20) of inverted papillomas with four cases exhibiting mutations at multiple exons. Seven cases had exon 7 mutations containing R248C, S249T, L259L, P260P, and V266M. Two cases had exon 10 and 15 mutations including A366D, H412H, E627D, D641N, and H643D; five cases had N653H. The most frequent mutation was identified at R248C. None of the inverted papillomas exhibited mutations in TP53. During a mean follow-up of 78 months, none had recurrence or developed urothelial carcinoma. These findings support the concept that low-grade and low-stage urothelial neoplasms arise in a background of molecular changes that are distinctly different from the molecular changes of high-grade and high-stage urothelial cancers.Keywords: urinary bladder, urinary tract, inverted papilloma, fibroblast growth factor receptor 3, tumorigenesis, TP mutations

Download full-text


Available from: Liang Cheng, Mar 26, 2014
  • Source
    • "However, this statement has been challenged because in rare cases, IUPs coexist with malignant urothelial neoplasms (Cheville et al. 2000). Molecular analyses also confirmed that IUPs arise on the basis of genetic changes, which are strikingly different from those of high-grade/high-stage urothelial neoplasms (Sung et al. 2006a; Lott et al. 2009). Therefore, distinction between IUP and inverted growth pattern of LG-UCC is essential. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The members of the claudin family are major integral transmembrane protein constituents of tight junctions. Normal and neoplastic tissues can be characterized by unique qualitative and quantitative distribution of claudin subtypes, which may be related to clinicopathological features. Differential diagnosis and prognosis of nonmuscle invasive tumor entities of urinary bladder epithelium are often challenging. The aim was to investigate the expression profile of claudins in inverted urothelial papillomas (IUPs), urothelial papillomas (UPs), papillary urothelial neoplasms of low malignant potential (PUNLMPs), and intraepithelial (Ta), low-grade urothelial cell carcinomas (LG-UCCs) in order to reveal potential prognostic and differential diagnostic values of certain claudins. Claudin-1, -2, -4, and -7 protein expressions detected by immunohistochemistry and clinical data were analyzed in 15 IUPs, 20 UPs, 20 PUNLMPs, and 20 LG-UCCs. UPs, PUNLMPs, and LG-UCCs showed significantly decreased claudin-1 expression in comparison to IUPs. LG-UCCs expressing claudin-4 over the median were associated with significantly shorter recurrence-free survival. PUNLMPs expressing claudin-1 over the median revealed significantly longer recurrence-free survival. High claudin-1 protein expression might help to differentiate IUP from UPs, PUNLMPs, and LG-UCCs. High claudin-4 expression may determine an unfavorable clinical course of LG-UCCs, while high claudin-1 expression in PUNLMP was associated with markedly better clinical outcome.
    Journal of Histochemistry and Cytochemistry 08/2011; 59(10):932-41. DOI:10.1369/0022155411418829 · 2.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A self-adaptive quantum radial basis function network (QRBFN) is proposed for classification applications. The QRBFN model is a three-layer structure. The hidden layer of the QRBFN model contains quantum function neurons, which are multilevel activation functions. Each quantum function neuron is composed of the sum of sigmoid functions shifted by quantum intervals. A self-adaptive learning algorithm, which consists of the self-clustering algorithm (SCA) and the backpropagation algorithm, is proposed. The proposed the SCA method is a fast, one-pass algorithm for a dynamic estimation of the number of clusters in an input data space. The backpropagation algorithm is used to tune the adjustable parameters. Simulation results were conducted to show the performance and applicability of the proposed model.
    Neural Networks, 2004. Proceedings. 2004 IEEE International Joint Conference on; 08/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tumor recurrence is a major clinical concern for patients with urothelial carcinoma of the urinary bladder. Traditional morphological analysis is of limited utility for identifying cases in which recurrence will occur. However, molecular and genetic analyses offer new perspectives on the prediction of bladder tumor recurrence. Recent studies have suggested that urothelial carcinogenesis occurs as a 'field effect' that can involve any number of sites in the bladder mucosa. Accumulating evidence supports the notion that resident urothelial stem cells in the affected field are transformed into cancer stem cells by acquiring genetic alterations that lead to tumor formation through clonal expansion. Both initial and recurrent tumors are derived from cancer stem cells in the affected field via two distinct molecular pathways. These provide a genetic framework for understanding urothelial carcinogenesis, tumor recurrence and progression: the FGFR3-associated pathway and the TP53-associated pathway. These two pathways are characterized by different genomic, epigenetic and gene-expression alterations. Their outcomes correlate with the markedly different clinical and pathologic features of both relatively indolent low-grade cancers and the aggressive high-grade cancers. As such, these molecular findings are potentially useful for counseling patients and for assessing risk of recurrence or biological aggressiveness of the patient's tumor. The molecular changes may additionally prove useful for developing preventive and therapeutic strategies for urothelial bladder cancer. A unifying model of urothelial carcinogenesis, tumor recurrence and progression is proposed in this review.
    Future Oncology 09/2009; 5(6):843-57. DOI:10.2217/fon.09.50 · 2.61 Impact Factor
Show more